{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T02:28:55Z","timestamp":1793759335494,"version":"4.6.1"},"reference-count":60,"publisher":"BMJ","issue":"5","license":[{"start":{"date-parts":[[2025,2,24]],"date-time":"2025-02-24T00:00:00Z","timestamp":1740355200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000738","name":"U.S. Department of Veterans Affairs","doi-asserted-by":"publisher","award":["I01BX003380"],"award-info":[{"award-number":["I01BX003380"]}],"id":[{"id":"10.13039\/100000738","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000738","name":"U.S. Department of Veterans Affairs","doi-asserted-by":"publisher","award":["I01BX005934"],"award-info":[{"award-number":["I01BX005934"]}],"id":[{"id":"10.13039\/100000738","id-type":"DOI","asserted-by":"publisher"}]},{"name":"U.S. National Institute of Health","award":["RO1 AG048923"],"award-info":[{"award-number":["RO1 AG048923"]}]},{"name":"U.S. National Institute of Health","award":["RO1 AG068030"],"award-info":[{"award-number":["RO1 AG068030"]}]},{"name":"U.S. National Institute of Health","award":["RO1 AG074010"],"award-info":[{"award-number":["RO1 AG074010"]}]},{"name":"U.S. National Institute of Health","award":["UH2 AG083258"],"award-info":[{"award-number":["UH2 AG083258"]}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Stroke Vasc Neurol"],"accepted":{"date-parts":[[2025,2,7]]},"published-print":{"date-parts":[[2025,10]]},"abstract":"<jats:p>Vascular dementia (VaD) is the second leading cause of dementia after Alzheimer\u2019s disease (AD). In comparison to AD, there is a decline in the incidence of VaD due to recent improvements in cardiovascular risk factors. Brain hypoperfusion and hypoxia due to vascular pathologies have been postulated as the primary disease mechanism of VaD. However, other factors such as neuroinflammation may also contribute to the development of VaD. Non-modifiable and modifiable risk factors have been attributed to VaD. The clinical features overlapping between AD and VaD create significant challenges for physicians. Newly developed biomarkers may potentially help differentiate VaD from other forms of dementia. Unlike AD, there is no Food and Drug Administration-approved drug or device for treating VaD. Current treatment options mainly target symptoms rather than slowing the development or progression of VaD. There are ongoing research studies testing the efficacy of various therapeutic strategies for VaD. In this narrative review, we will summarise current findings on epidemiology, attributed risk factors and disease mechanisms, as well as emphasise the importance of optimising lifestyle modifications and comorbid condition management in preventing or slowing down the development of VaD. Finally, current therapies and ongoing research studies of novel therapeutic interventions such as stem-cell therapy and neuromodulation are highlighted.<\/jats:p>","DOI":"10.1136\/svn-2025-004048","type":"journal-article","created":{"date-parts":[[2025,2,25]],"date-time":"2025-02-25T02:35:18Z","timestamp":1740450918000},"page":"542-550","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":34,"title":["Updates on vascular dementia"],"prefix":"10.1136","volume":"10","author":[{"given":"Sabrina","family":"Ng","sequence":"first","affiliation":[{"name":"Department of Neurology, Icahn School of Medicine, New York, New York, USA"},{"name":"Research and Development, James J Peters VA Medical Center, Bronx, New York, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ava","family":"Hornblass","sequence":"additional","affiliation":[{"name":"Department of Neurology, Icahn School of Medicine, New York, New York, USA"},{"name":"Research and Development, James J Peters VA Medical Center, Bronx, New York, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Parnian","family":"Habibi","sequence":"additional","affiliation":[{"name":"Department of Neurology, The University of Minnesota, Minneapolis, Minnesota, USA"},{"name":"N Bud Grossman Center for Memory Research and Care, The University of Minnesota, Minneapolis, Minnesota, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-6493-6635","authenticated-orcid":false,"given":"Salman","family":"Ikramuddin","sequence":"additional","affiliation":[{"name":"Department of Neurology, The University of Minnesota, Minneapolis, Minnesota, USA"},{"name":"Neurology, University of Texas Health Sciences, Houston, Texas, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Neurology, The University of Minnesota, Minneapolis, Minnesota, USA"},{"name":"Blake School, Hopkins, Minnesota, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wayne","family":"Feng","sequence":"additional","affiliation":[{"name":"Neurology, Duke University School of Medicine, Durham, North Carolina, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0601-6826","authenticated-orcid":false,"given":"Dongming","family":"Cai","sequence":"additional","affiliation":[{"name":"Department of Neurology, Icahn School of Medicine, New York, New York, USA"},{"name":"Research and Development, James J Peters VA Medical Center, Bronx, New York, USA"},{"name":"Department of Neurology, The University of Minnesota, Minneapolis, Minnesota, USA"},{"name":"N Bud Grossman Center for Memory Research and Care, The University of Minnesota, Minneapolis, Minnesota, USA"},{"name":"GRECC, Minneapolis VA Health Care System, Minneapolis, Minnesota, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2025,2,24]]},"reference":[{"key":"2025102713051382000_10.5.542.1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2019.04.034"},{"key":"2025102713051382000_10.5.542.2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1504327"},{"key":"2025102713051382000_10.5.542.3","doi-asserted-by":"crossref","first-page":"e443","DOI":"10.1016\/S2468-2667(24)00120-8","article-title":"Changes in prevalence and incidence of dementia and risk factors for dementia: an analysis from cohort studies","volume":"9","author":"Mukadam","year":"2024","journal-title":"Lancet Public Health"},{"key":"2025102713051382000_10.5.542.4","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1212\/WNL.0b013e3182553be6","article-title":"Is dementia incidence declining?: Trends in dementia incidence since 1990 in the Rotterdam Study","volume":"78","author":"Schrijvers","year":"2012","journal-title":"Neurology (ECronicon)"},{"key":"2025102713051382000_10.5.542.5","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1111\/psyg.12865","article-title":"Secular trends in the prevalence of dementia based on a community-based complete enumeration in Japan: the Nakayama Study","volume":"22","author":"Shimizu","year":"2022","journal-title":"Psychogeriatrics"},{"key":"2025102713051382000_10.5.542.6","doi-asserted-by":"crossref","unstructured":"Gu X , Shi Z , Liu S , et al . n.d. Incidence and risk factors of dementia and the primary subtypes in northern rural China. Medicine (Abingdon) 100:e25343. doi:10.1097\/MD.0000000000025343","DOI":"10.1097\/MD.0000000000025343"},{"key":"2025102713051382000_10.5.542.7","doi-asserted-by":"crossref","unstructured":"Legdeur N , van der Lee SJ , de Wilde M , et al . The association of vascular disorders with incident dementia in different age groups. Alz Res Therapy 2019;11. doi:10.1186\/s13195-019-0496-x","DOI":"10.1186\/s13195-019-0496-x"},{"key":"2025102713051382000_10.5.542.8","doi-asserted-by":"crossref","first-page":"105864","DOI":"10.1016\/j.jstrokecerebrovasdis.2021.105864","article-title":"Emerging Concepts in Vascular Dementia: A Review","volume":"30","author":"Bir","year":"2021","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"2025102713051382000_10.5.542.9","doi-asserted-by":"publisher","DOI":"10.2337\/dc15-1588"},{"key":"2025102713051382000_10.5.542.10","first-page":"1412","article-title":"Genetic Determinants of Vascular Dementia","volume":"40","author":"Pathan","year":"2024","journal-title":"Can J Cardiol"},{"key":"2025102713051382000_10.5.542.11","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1016\/S0140-6736(77)92576-4","article-title":"Chronic familial vascular encephalopathy","volume":"1","author":"Stevens","year":"1977","journal-title":"Lancet"},{"key":"2025102713051382000_10.5.542.12","doi-asserted-by":"crossref","first-page":"5973","DOI":"10.1002\/alz.14115","article-title":"A genome\u2010wide association meta\u2010analysis of all\u2010cause and vascular dementia","volume":"20","year":"2024","journal-title":"Alzheimer's &amp; Dementia"},{"key":"2025102713051382000_10.5.542.13","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.l1495"},{"key":"2025102713051382000_10.5.542.14","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1003016","article-title":"The association of depression with subsequent dementia diagnosis: A Swedish nationwide cohort study from 1964 to 2016","volume":"17","author":"Holmquist","year":"2020","journal-title":"PLoS Med"},{"key":"2025102713051382000_10.5.542.15","doi-asserted-by":"publisher","DOI":"10.1016\/j.smrv.2017.06.010"},{"key":"2025102713051382000_10.5.542.16","doi-asserted-by":"crossref","unstructured":"Kjeldsen EW , Frikke-Schmidt R . Causal cardiovascular risk factors for dementia - insights from observational and genetic studies. Cardiovasc Res 2024.:cvae235. doi:10.1093\/cvr\/cvae235","DOI":"10.1093\/cvr\/cvae235"},{"key":"2025102713051382000_10.5.542.17","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(16)30029-1"},{"key":"2025102713051382000_10.5.542.18","doi-asserted-by":"crossref","first-page":"100148","DOI":"10.1016\/j.cccb.2022.100148","article-title":"Vascular pathology and pathogenesis of cognitive impairment and dementia in older adults","volume":"3","author":"Agrawal","year":"2022","journal-title":"Cerebral Circulation - Cognition and Behavior"},{"key":"2025102713051382000_10.5.542.19","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.20220380"},{"key":"2025102713051382000_10.5.542.20","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1186\/s40478-023-01590-1","article-title":"Chronic cerebral hypoperfusion: a critical feature in unravelling the etiology of vascular cognitive impairment","volume":"11","author":"Rajeev","year":"2023","journal-title":"Acta Neuropathol Commun"},{"key":"2025102713051382000_10.5.542.21","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2021.727590"},{"key":"2025102713051382000_10.5.542.22","doi-asserted-by":"publisher","DOI":"10.1016\/j.expneurol.2015.05.006"},{"key":"2025102713051382000_10.5.542.23","doi-asserted-by":"crossref","first-page":"321209","DOI":"10.1155\/2014\/321209","article-title":"Astrocyte-secreted matricellular proteins in CNS remodelling during development and disease","volume":"2014","author":"Jones","year":"2014","journal-title":"Neural Plast"},{"key":"2025102713051382000_10.5.542.24","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-14373-2"},{"key":"2025102713051382000_10.5.542.25","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.neubiorev.2019.04.014","article-title":"Neurofilament light chain protein in neurodegenerative dementia: A systematic review and network meta-analysis","volume":"102","author":"Zhao","year":"2019","journal-title":"Neurosci Biobehav Rev"},{"key":"2025102713051382000_10.5.542.26","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1159\/000488318","article-title":"Lower Plasma Klotho Concentrations Are Associated with Vascular Dementia but Not Late-Onset Alzheimer\u2019s Disease","volume":"64","author":"Brombo","year":"2018","journal-title":"Gerontology"},{"key":"2025102713051382000_10.5.542.27","doi-asserted-by":"crossref","first-page":"2579","DOI":"10.4103\/NRR.NRR-D-23-01938","article-title":"Molecular biomarkers for vascular cognitive impairment and dementia: the current status and directions for the future","volume":"19","author":"Hosoki","year":"2024","journal-title":"Neural Regen Res"},{"key":"2025102713051382000_10.5.542.28","doi-asserted-by":"publisher","DOI":"10.1038\/s41380-023-02215-8"},{"key":"2025102713051382000_10.5.542.29","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2018.00467"},{"key":"2025102713051382000_10.5.542.30","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1177\/0271678X221135353","article-title":"Recent advances in arterial spin labeling perfusion MRI in patients with vascular cognitive impairment","volume":"43","author":"Huang","year":"2023","journal-title":"J Cereb Blood Flow Metab"},{"key":"2025102713051382000_10.5.542.31","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.jalz.2017.09.007","article-title":"Progress toward standardized diagnosis of vascular cognitive impairment: Guidelines from the Vascular Impairment of Cognition Classification Consensus Study","volume":"14","author":"Skrobot","year":"2018","journal-title":"Alzheimer's &amp; Dementia"},{"key":"2025102713051382000_10.5.542.32","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1080\/14737175.2023.2273393","article-title":"Current perspectives on prevention of vascular cognitive impairment and promotion of vascular brain health","volume":"24","author":"Kalaria","year":"2024","journal-title":"Expert Rev Neurother"},{"key":"2025102713051382000_10.5.542.33","doi-asserted-by":"publisher","DOI":"10.1177\/17474930211073387"},{"key":"2025102713051382000_10.5.542.34","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1002\/gps.2340","article-title":"The long-term efficacy and tolerability of donepezil in patients with vascular dementia","volume":"25","author":"Wilkinson","year":"2010","journal-title":"Int J Geriatr Psychiatry"},{"key":"2025102713051382000_10.5.542.35","doi-asserted-by":"crossref","unstructured":"Birks J , McGuinness B , Craig D . Rivastigmine for vascular cognitive impairment. Cochrane Database Syst Rev 2013;CD004744. doi:10.1002\/14651858.CD004744.pub3","DOI":"10.1002\/14651858.CD004744.pub3"},{"key":"2025102713051382000_10.5.542.36","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1212\/01.wnl.0000266625.31615.f6","article-title":"Galantamine treatment of vascular dementia: a randomized trial","volume":"69","author":"Auchus","year":"2007","journal-title":"Neurology (ECronicon)"},{"key":"2025102713051382000_10.5.542.37","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1159\/000444253","article-title":"Efficacy of Cholinesterase Inhibitors in Vascular Dementia: An Updated Meta-Analysis","volume":"75","author":"Chen","year":"2016","journal-title":"Eur Neurol"},{"key":"2025102713051382000_10.5.542.38","doi-asserted-by":"publisher","DOI":"10.1161\/01.STR.0000020094.08790.49"},{"key":"2025102713051382000_10.5.542.39","doi-asserted-by":"publisher","DOI":"10.1097\/00004850-200211000-00005"},{"key":"2025102713051382000_10.5.542.40","article-title":"Memantine for dementia","volume":"3","author":"McShane","year":"2019","journal-title":"Cochrane Database Syst Rev"},{"key":"2025102713051382000_10.5.542.41","doi-asserted-by":"crossref","first-page":"3272","DOI":"10.3390\/ijms21093272","article-title":"Combination Drug Therapy for the Management of Alzheimer\u2019s Disease","volume":"21","author":"Kabir","year":"2020","journal-title":"Int J Mol Sci"},{"key":"2025102713051382000_10.5.542.42","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000029307","article-title":"A systematic review of the efficacy of donepezil hydrochloride combined with nimodipine on treating vascular dementia","volume":"101","author":"Yang","year":"2022","journal-title":"Medicine (Baltimore)"},{"key":"2025102713051382000_10.5.542.43","doi-asserted-by":"crossref","first-page":"104073","DOI":"10.1016\/j.archger.2020.104073","article-title":"The CITIMEM study: A pilot study. Optimizing pharmacological treatment in dementia","volume":"89","author":"Gareri","year":"2020","journal-title":"Arch Gerontol Geriatr"},{"key":"2025102713051382000_10.5.542.44","doi-asserted-by":"publisher","DOI":"10.1177\/153331750301800508"},{"key":"2025102713051382000_10.5.542.45","doi-asserted-by":"publisher","DOI":"10.1161\/STROKEAHA.117.017319"},{"key":"2025102713051382000_10.5.542.46","doi-asserted-by":"crossref","first-page":"267","DOI":"10.14283\/jpad.2019.28","article-title":"Mediterranean-Dash Intervention for Neurodegenerative Delay (MIND) Diet Slows Cognitive Decline After Stroke","volume":"6","author":"Cherian","year":"2019","journal-title":"J Prev Alzheimers Dis"},{"key":"2025102713051382000_10.5.542.47","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1002\/acn3.633","article-title":"Effect of smoking cessation on the risk of dementia: a longitudinal study","volume":"5","author":"Choi","year":"2018","journal-title":"Ann Clin Transl Neurol"},{"key":"2025102713051382000_10.5.542.48","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1038\/s41392-019-0064-7","article-title":"The effect of selective serotonin reuptake inhibitors on cognitive function in patients with Alzheimer\u2019s disease and vascular dementia: focusing on fluoxetine with long follow-up periods","volume":"4","author":"Xie","year":"2019","journal-title":"Signal Transduct Target Ther"},{"key":"2025102713051382000_10.5.542.49","first-page":"e1732","article-title":"Atrial fibrillation, antithrombotic treatment, and cognitive aging: A population-based study","volume":"91","author":"Ding","year":"2018","journal-title":"Neurology (ECronicon)"},{"key":"2025102713051382000_10.5.542.50","doi-asserted-by":"crossref","first-page":"841","DOI":"10.14336\/AD.2020.1111","article-title":"Effects of Antihypertensive Drugs on Cognitive Function in Elderly Patients with Hypertension: A Review","volume":"12","author":"Yang","year":"2021","journal-title":"Aging Dis"},{"key":"2025102713051382000_10.5.542.51","doi-asserted-by":"crossref","first-page":"2100","DOI":"10.1111\/jch.14373","article-title":"The effects of blood pressure on post stroke cognitive impairment: BP and PSCI","volume":"23","author":"Wang","year":"2021","journal-title":"J of Clinical Hypertension"},{"key":"2025102713051382000_10.5.542.52","doi-asserted-by":"crossref","unstructured":"Zhang X , Wen J , Zhang Z . \u201cStatins use and risk of dementia: a dose\u2013response meta analysis\u201d, medicine (united states). 2018. doi:10.1097\/MD.0000000000011304","DOI":"10.1097\/MD.0000000000011304"},{"key":"2025102713051382000_10.5.542.53","doi-asserted-by":"publisher","DOI":"10.1111\/jgs.18405"},{"key":"2025102713051382000_10.5.542.54","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(20)30173-3"},{"key":"2025102713051382000_10.5.542.55","doi-asserted-by":"crossref","first-page":"591","DOI":"10.3233\/JAD-150057","article-title":"A Nutritional Formulation for Cognitive Performance in Mild Cognitive Impairment: A Placebo-Controlled Trial with an Open-Label Extension","volume":"48","author":"Remington","year":"2015","journal-title":"JAD"},{"key":"2025102713051382000_10.5.542.56","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.6156","article-title":"Effect of Sodium Benzoate on Cognitive Function Among Patients With Behavioral and Psychological Symptoms of Dementia: Secondary Analysis of a Randomized Clinical Trial","volume":"4","author":"Lin","year":"2021","journal-title":"JAMA Netw Open"},{"key":"2025102713051382000_10.5.542.57","doi-asserted-by":"crossref","first-page":"101669","DOI":"10.1016\/j.trim.2022.101669","article-title":"A clinical research of 11cases of human umbilical cord mesenchymal stem cells for curing senile vascular dementia","volume":"74","author":"Master","year":"2022","journal-title":"Transpl Immunol"},{"key":"2025102713051382000_10.5.542.58","doi-asserted-by":"crossref","first-page":"813597","DOI":"10.3389\/fneur.2022.813597","article-title":"Therapeutic Effect of Repetitive Transcranial Magnetic Stimulation for Post-stroke Vascular Cognitive Impairment: A Prospective Pilot Study","volume":"13","author":"Cha","year":"2022","journal-title":"Front Neurol"},{"key":"2025102713051382000_10.5.542.59","doi-asserted-by":"crossref","first-page":"114229","DOI":"10.1016\/j.bbr.2022.114229","article-title":"Effects of repetitive transcranial magnetic stimulation on post-stroke patients with cognitive impairment: A systematic review and meta-analysis","volume":"439","author":"Li","year":"2023","journal-title":"Behav Brain Res"},{"key":"2025102713051382000_10.5.542.60","doi-asserted-by":"crossref","first-page":"623315","DOI":"10.3389\/fnhum.2021.623315","article-title":"Effects of Transcranial Direct Current Stimulation (tDCS) on Cognitive Performance and Cerebral Oxygen Hemodynamics: A Systematic Review","volume":"15","author":"Figeys","year":"2021","journal-title":"Front Hum Neurosci"}],"container-title":["Stroke and Vascular Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/svn-2025-004048","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T20:05:38Z","timestamp":1761595538000},"score":1,"resource":{"primary":{"URL":"https:\/\/svn.bmj.com\/lookup\/doi\/10.1136\/svn-2025-004048"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,24]]},"references-count":60,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2025,10,27]]},"published-print":{"date-parts":[[2025,10]]}},"alternative-id":["10.1136\/svn-2025-004048"],"URL":"https:\/\/doi.org\/10.1136\/svn-2025-004048","relation":{},"ISSN":["2059-8688","2059-8696"],"issn-type":[{"value":"2059-8688","type":"print"},{"value":"2059-8696","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,24]]}}}